Your browser doesn't support javascript.
COVID-19 vaccine prioritisation for type 1 and type 2 diabetes.
Powers, Alvin C; Aronoff, David M; Eckel, Robert H.
  • Powers AC; Vanderbilt Diabetes Center, Vanderbilt University Medical Center, Nashville, TN 37232-0475, USA; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-0475, USA. Electronic address: Al.Powers@vumc.org.
  • Aronoff DM; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-0475, USA.
  • Eckel RH; Division of Endocrinology, Metabolism and Diabetes and Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Lancet Diabetes Endocrinol ; 9(3): 140-141, 2021 03.
Article in English | MEDLINE | ID: covidwho-1032104

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / COVID-19 Vaccines / COVID-19 / Health Priorities Type of study: Observational study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Lancet Diabetes Endocrinol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / COVID-19 Vaccines / COVID-19 / Health Priorities Type of study: Observational study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Lancet Diabetes Endocrinol Year: 2021 Document Type: Article